National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
NCI Drug Dictionary
Page Options
Print This Page  Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
Contains
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

arsenic trioxide  Patient Information
A small-molecule arsenic compound with antineoplastic activity. The mechanism of action of arsenic trioxide is not completely understood. This agent causes damage to or degradation of the promyelocytic leukemia protein/retinoic acid receptor-alpha (PML/RARa) fusion protein; induces apoptosis in acute promyelocytic leukemia (APL) cells and in many other tumor cell types; promotes cell differentiation and suppresses cell proliferation in many different tumor cell types; and is pro-angiogenic. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
Synonyms:Arsenic (III) Oxide
Arsenic Sesquioxide
Arsenous Acid
Arsenous Acid Anhydride
Arsenous Oxide
White Arsenic
US brand name:Trisenox
Abbreviation:AS2O3


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov